MVA Pfs25-IMX313
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MVA Pfs25-IMX313, covering 2017-07-17 to 2017-07-17. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial to Assess the Safety and Immunogenicity of New Malaria Vaccine Candidates ChAd63 Pfs25-IMX313 and MVA Pfs25-IMX313 [Phase 1]